logo

FDA approves Vir Biotechnology antibody drug for emergencies

Pension Times Finance Experts
· 1 min read

George Scangos, President and CEO of Vir Biotechnology, joined Yahoo Finance's Julia LaRoche and Adam Shapiro to discuss the latest on the company's COVID-19 antibody treatment.

Pension Times Finance Experts

Pension Times Finance Experts

Written collaboratively by Pension Times’ in-house finance experts.
The content on pensiontimes.co.uk is for informational and educational purposes only and should not be construed as professional financial advice. Should you need such advice, consult a licensed financial advisor. Any references to products, offers, rates and services from third parties advertised are served by those third parties and are subject to change. We may have financial relationships with some of the companies mentioned on this website. We strive to write accurate and genuine reviews and articles, and all views and opinions expressed are solely those of the authors